zidovudine has been researched along with Cardiomyopathies, Primary in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (35.71) | 18.2507 |
2000's | 7 (50.00) | 29.6817 |
2010's | 2 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abuin, A; Cucoranu, I; Fields, E; Green, E; He, S; Hosseini, SH; Hoying, A; Johnson, D; Kohler, JJ; Lewis, W; Raper, CM; Russ, R | 1 |
Balcarek, K; Beauvoit, B; Bonnet, J; Deveaud, C; Kirschner, J; Lebrecht, D; Venhoff, AC; Venhoff, N; Walker, UA | 1 |
Colan, SD; Mittleman, MA; Oleske, JM; Patel, K; Seage, GR; Van Dyke, RB | 1 |
Campen, MJ; Cook, DL; Cossey, PY; Divi, RL; Hahn, FF; Lund, AK; Nagashima, K; Poirier, MC; Walker, DM; Walker, VE | 1 |
Giacomet, V; ViganĂ², A | 1 |
Bowles, NE; Carabello, B; DeFreitas, G; Jimenez, S; Kearney, DL; Nelson, DP; Purevjav, E; Sanchez, XV; Shearer, WT; Taylor, MD; Towbin, JA; Varela, JJ; Vatta, M | 1 |
Degli Esposti, M; Generowicz, M; Linnane, AW; Luff, AR; Nagley, P | 1 |
Domanski, MJ; Egan, D; Follmann, DA; Pizzo, PA; Scalise, PP; Sloas, MM; Tucker, EE | 1 |
Boon, NA; Currie, PF | 1 |
Csete, B; Endrei, D; Fischer, GM; Habon, T; Nemeti, B; Sumegi, B; Szabados, E; Toth, K; Trombitas, K | 1 |
Mathew, J; Prabhakar, S; Pulvirenti, J; Roy, VP | 1 |
Bruggeman, L; Grupp, G; Grupp, IL; Hoit, B; Klotman, P; Lewis, W; Morris, R; Samarel, AM | 1 |
Lewis, W | 1 |
Haase, CP; Hoit, BD; Lewis, W; Raidel, SM; Russ, RB; Samarel, AM; Sutliff, RL | 1 |
1 review(s) available for zidovudine and Cardiomyopathies, Primary
Article | Year |
---|---|
Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children.
Topics: Acidosis, Lactic; Anti-HIV Agents; Cardiomyopathies; Child; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Mitochondria; Nucleosides; Polyneuropathies; Reverse Transcriptase Inhibitors; Zidovudine | 2005 |
13 other study(ies) available for zidovudine and Cardiomyopathies, Primary
Article | Year |
---|---|
Transgenic mitochondrial superoxide dismutase and mitochondrially targeted catalase prevent antiretroviral-induced oxidative stress and cardiomyopathy.
Topics: Aconitate Hydratase; Animals; Anti-HIV Agents; Cardiomyopathies; Catalase; Female; Gene Expression; Hydrogen Peroxide; Male; Mice; Mice, Congenic; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microscopy, Electron, Transmission; Mitochondria, Heart; Models, Cardiovascular; Myocardium; Oxidative Stress; Phenotype; Superoxide Dismutase; Zidovudine | 2009 |
Role of pyrimidine depletion in the mitochondrial cardiotoxicity of nucleoside analogue reverse transcriptase inhibitors.
Topics: Animals; Anti-HIV Agents; Cardiomyopathies; Cardiotoxins; Dietary Supplements; DNA Copy Number Variations; DNA, Mitochondrial; Electron Transport Complex IV; Heart; HIV Infections; Mice; Mice, Inbred BALB C; Mitochondria, Heart; Mutation; Nucleosides; Pyrimidines; Reactive Oxygen Species; Reverse Transcriptase Inhibitors; Uridine; Zalcitabine; Zidovudine | 2010 |
The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1.
Topics: Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cardiomyopathies; Cardiotonic Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Digoxin; Female; Follow-Up Studies; HIV Seropositivity; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Pregnancy; Prenatal Exposure Delayed Effects; Proportional Hazards Models; Prospective Studies; Treatment Outcome; United States; Zalcitabine; Zidovudine | 2012 |
Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3'-azido-3'-deoxythymidine.
Topics: Age Factors; Animals; Animals, Newborn; Anti-HIV Agents; Body Weight; Cardiomyopathies; DNA, Mitochondrial; Drug Interactions; Electrocardiography; Electron Transport Complex IV; Female; Lamivudine; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred C57BL; Mitochondria, Heart; Mutation; Myocardium; Organ Size; Pilot Projects; Pregnancy; Sex Factors; Zidovudine | 2004 |
Myocardial Fas ligand expression increases susceptibility to AZT-induced cardiomyopathy.
Topics: Animals; Anti-HIV Agents; Apoptosis; Blotting, Western; Cardiomyopathies; Cardiomyopathy, Dilated; Echocardiography; Fas Ligand Protein; HIV Seropositivity; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Troponin I; Zidovudine | 2007 |
The universality of bioenergetic disease and amelioration with redox therapy.
Topics: Animals; Cardiomyopathies; Coenzymes; Humans; Mitochondria, Heart; Mitochondrial Myopathies; Muscle, Skeletal; Oxidation-Reduction; Rats; Submitochondrial Particles; Ubiquinone; Zidovudine | 1995 |
Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Cardiomyopathies; CD4 Lymphocyte Count; Child, Preschool; Didanosine; Dose-Response Relationship, Drug; Echocardiography; Female; Heart; HIV; Humans; Infant; Infant, Newborn; Male; Medical Records; Retrospective Studies; Severity of Illness Index; Zalcitabine; Zidovudine | 1995 |
Cardiac involvement in human immunodeficiency virus infection.
Topics: Cardiomyopathies; Cytomegalovirus Infections; Heart Diseases; HIV Infections; Humans; Myocarditis; Zidovudine | 1993 |
Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat.
Topics: ADP Ribose Transferases; Animals; Anti-HIV Agents; Cardiomyopathies; DNA, Mitochondrial; Electrocardiography; Energy Metabolism; Microscopy, Electron; NAD; Poly(ADP-ribose) Polymerases; Rats; Reactive Oxygen Species; Zidovudine | 1999 |
Frequency and factors associated with cardiomyopathy in patients with human immunodeficiency virus infection in an inner-city hospital.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cardiomyopathies; Chi-Square Distribution; Chicago; Female; Heart Failure; HIV Infections; Hospitals, Urban; Humans; Hypertension; Male; Zidovudine | 1999 |
Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Cardiomyopathies; Disease Models, Animal; HIV-1; Mice; Mice, Transgenic; Reverse Transcriptase Inhibitors; Ultrasonography; Zidovudine | 2000 |
Absence of cardiac toxicity of zidovudine in infants.
Topics: Adult; Animals; Anti-HIV Agents; Cardiomyopathies; Child; Female; Heart Ventricles; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Prenatal Exposure Delayed Effects; Zidovudine | 2001 |
Combined antiretroviral therapy causes cardiomyopathy and elevates plasma lactate in transgenic AIDS mice.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atrial Natriuretic Factor; Calcium-Transporting ATPases; Cardiomyopathies; Drug Therapy, Combination; Echocardiography; Gene Expression; HIV Protease Inhibitors; Indinavir; Lactic Acid; Lamivudine; Mice; Mice, Transgenic; Microscopy, Electron; Myocardium; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Zidovudine | 2001 |